![]() |
市場調查報告書
商品編碼
1420194
南美洲和中美洲順勢療法市場預測至 2030 年 - 區域分析 - 按來源、類型、應用和配銷通路South & Central America Homeopathy Market Forecast to 2030 - Regional Analysis - by Source, Type, Application, and Distribution Channel |
2022年,中南美洲順勢療法市場價值為3.2247億美元,預計2030年將達到9.830億美元;預計2022年至2030年CAGR為15.0%。
巴西和阿根廷的有利法規推動了南美洲和中美洲順勢療法市場
在巴西,順勢療法作為替代醫學被廣泛使用。順勢療法於 1840 年由法國順勢療法醫生引進巴西。巴西大約有 15,000 名順勢療法醫生、專業藥劑師、獸醫和牙醫從事這項職業。這總體上簡要概述了順勢療法在巴西的引入時間和技術現狀。 2020 年,超過 5,000 萬巴西人至少使用過一次順勢療法藥物治療自己。在巴西,順勢療法受到 Anvisa 的監管,該機構為藥房的生產和處方、工業化和這些藥物的銷售制定了規則,以保證其品質。工業化順勢療法藥物可以在藥局和藥局找到,並且必須清楚註明首字母 MS 和始終以數字開頭的 8 至 13 個數字序列。此外,還有大量的順勢療法實驗室和藥房生產和銷售工業化順勢療法藥物。布瓦龍是全球最大的順勢療法藥物實驗室,由於該國的需求量很大,開始銷售產品。因此,上述因素在預測期內正在推動順勢療法市場。在阿根廷,順勢療法得到了公共衛生部的正式認可,因此藥房和實驗室在與一般療法相同的控制下製備和銷售藥物。目前有超過 500 名醫師從事統一順勢療法。老年人口的增加、慢性疾病盛行率的增加以及對順勢療法藥物需求的增加是有助於順勢療法藥物在阿根廷發展的一些因素。根據 IDF 2021 年糖尿病圖譜報告,10.5% 的成年人口(20-79 歲)患有糖尿病,其中幾乎一半人不知道自己患有這種疾病。根據 LIGA MEDICORUM HOMOEOPATHICA INTERNATIONALIS 的說法,阿根廷的順勢療法因其眾所周知的傳統和高學術標準而受到認可。阿根廷的順勢療法培訓由遵循國際順勢療法聯盟 (LMHI) 建議的教育標準的機構保證為醫生、牙醫、獸醫和藥劑師提供高級課程。由於阿根廷機構的卓越水平,世界各地經常需要來自阿根廷機構的教師。這表明阿根廷順勢療法自托馬斯·巴勃羅·帕斯切羅博士(LMHI 著名院長)時代以來仍然有效。阿根廷順勢療法醫學協會聯合會(FAMHA,即阿根廷順勢療法醫學協會聯合會)聯合了著名的教育機構,致力於傳承這項傳統。 FAMHA 繼續為順勢療法的法律認可而奮鬥。在這方面,順勢療法醫生可以開立順勢療法,但這種治療方法的實踐尚未被視為醫療行為。儘管受到衛生系統中保守團體的批評和攻擊,但阿根廷的順勢療法在其他衛生環境中受到所有受益於這種治療方法的患者的讚賞。
南美洲和中美洲順勢療法市場概述
南美洲和中美洲順勢療法市場分為巴西、阿根廷以及南美洲和中美洲其他地區。由於順勢療法產品和服務的可用性和可及性不斷增加,衛生當局加強監管支持以確保順勢療法產品的銷售,市場可能會在預測期內得到推動。
南美洲和中美洲順勢療法市場收入及 2030 年預測(百萬美元)
南美洲和中美洲順勢療法市場區隔
南美洲和中美洲順勢療法市場根據來源、類型、應用、配銷通路和國家進行細分。根據消息來源,南美洲和中美洲順勢療法市場分為植物、動物和礦物質。 2022 年,植物細分市場佔據最大的市場。
根據類型,南美洲和中美洲順勢療法市場分為稀釋劑、酊劑、生化劑、軟膏、片劑等。 2022 年,稀釋細分市場佔據最大的市場佔有率。
根據應用,南美洲和中美洲順勢療法市場分為鎮痛和解熱、呼吸、神經病學、免疫學、胃腸病學、皮膚病學等。 2022 年,免疫學領域佔據最大的市場佔有率。
根據配銷通路,南美洲和中美洲順勢療法市場分為順勢療法診所、零售藥局、電子零售商等。 2022 年,順勢療法診所細分市場佔據最大的市場佔有率。
根據國家/地區,南美洲和中美洲順勢療法市場分為巴西、阿根廷以及南美洲和中美洲其他地區。 2022 年,巴西在南美洲和中美洲順勢療法市場佔有率中佔據主導地位。
Fourrts、Boiron、Biologische Heilmittel Heel GmbH、DHU-Arzneimittel GmbH & Co. KG 和 Dr Reckeweg & Co GmbH 是南美洲和中美洲順勢療法市場的一些領先參與者。
The South & Central America homeopathy market was valued at US$ 322.47 million in 2022 and is expected to reach US$ 983.00 million by 2030; it is estimated to grow at a CAGR of 15.0% from 2022 to 2030.
Favorable Regulations in Brazil and Argentina fuel the South & Central America Homeopathy Market
In Brazil, there is widespread use of homeopathy as an alternative medicine. Homeopathy was introduced to Brazil in 1840 by the French homeopathic physician. There are approximately 15,000 homeopathic physicians, specialized pharmacists, veterinarians, and dental surgeons practicing the profession in Brazil. This generally states a brief overview on when homeopathy was introduced in Brazil and the state of art. In 2020, over 50 million Brazilians had treated themselves with homeopathic medications at least once. In Brazil, homeopathy is regulated by Anvisa, which creates rules for the production and prescription by pharmacies, industrialization, and sale of these medications, in an attempt to guarantee their quality. Industrialized homeopathic medications can be found in pharmacies and drugstores and must clearly state the initials MS and a sequence of 8 to 13 numbers which always start with number. In addition, there are a significant number of homeopathic laboratories and pharmacies producing and selling industrialized homeopathic medicines. Boiron, which is the biggest worldwide laboratory of homeopathic medications started selling its products owing to high demand in the country. Thus, abovementioned factors are driving the homeopathy market during the forecast period. In Argentina, homoeopathic remedies are duly accepted by the Ministry of Public Health, owing to which pharmacies and laboratories prepare and sell their medicines under the same controls as those on general remedies. At present there are more than 500 physicians practicing Unified Homoeopathy. Rise in geriatric population, increase in the prevalence of chronic disorders, and rise in the demand for homeopathy medicines are some factors that will aid the growth of homeopathic medicine in Argentina. As per the IDF Diabetes Atlas 2021 reports, 10.5% of the adult population (20-79 years) has diabetes, with almost half unaware of the condition. According to the LIGA MEDICORUM HOMOEOPATHICA INTERNATIONALIS, homeopathy in Argentina is recognized for its well-known tradition and its high academic standards. Homeopathic training in Argentina is guaranteed in high-level courses for medical doctors, dentists, veterinarians and pharmacists by institutions that follow the educational standards suggested by the Liga Medicorum Homoeopathica Internationalis (LMHI). Teachers from Argentinean institutions are frequently requested in different countries of the world because of their level of excellence. This shows that Argentinean homeopathy is still valid since the times of Dr. Tomas Pablo Paschero, who was a well-known President of the LMHI. The Federacion de Asociaciones Medicas Homeopaticas Argentinas (FAMHA, or Federation of Argentinean Homeopathic Medical Associations) unites prestigious educational institutions that keep the legacy alive. The FAMHA continues fighting for homeopathy's legal recognition. In that regard, homeopaths are allowed to prescribe homeopathic remedies, but the practice of this therapeutic method has not yet been considered a medical act. Despite being criticized and attacked by conservative groups among the health system, homeopathy in Argentina is appreciated in other health environments and by all the patients who have benefited from this healing methodology.
South & Central America Homeopathy Market Overview
The South & Central America homeopathy market is segmented into Brazil, Argentina, and the Rest of South & Central America. The market is likely to propel during the forecast period owing to the increasing availability and accessibility of homeopathic products and service, the increasing regulatory support by the health authorities ensuring the sale of homeopathic products.
South & Central America Homeopathy Market Revenue and Forecast to 2030 (US$ Million)
South & Central America Homeopathy Market Segmentation
The South & Central America homeopathy market is segmented based on source, type, application, distribution channel, and country. Based on sources, the South & Central America homeopathy market is segmented into plants, animals, and minerals. The plants segment held the largest market share in 2022.
Based on type, the South & Central America homeopathy market is segmented into dilutions, tinctures, biochemics, ointments, tablets, and others. The dilutions segment held the largest market share in 2022.
Based on application, the South & Central America homeopathy market is segmented into analgesic and antipyretic, respiratory, neurology, immunology, gastroenterology, dermatology, and others. The immunology segment held the largest market share in 2022.
Based on distribution channel, the South & Central America homeopathy market is segmented into homeopathic clinics, retail pharmacies, e-retailers, and others. The homeopathic clinics segment held the largest market share in 2022.
Based on country, the South & Central America homeopathy market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America homeopathy market share in 2022.
Fourrts, Boiron, Biologische Heilmittel Heel GmbH, DHU-Arzneimittel GmbH & Co. KG, and Dr Reckeweg & Co GmbH are some of the leading players operating in the South & Central America homeopathy market.